ANTI-GADAntibodies to Glutamic Acid Decarboxylase (enzyme)
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
(32) We only measured anti-GAD antibodies, which might result in underestimation of the prevalence of diabetes predisposition in our cohort.
This case illustrates similar findings in anti-GAD encephalitis with CT perfusion.
He presented with subsequent left upper extremity focal SLS diagnosed two years before this admission by anti-GAD antibody elevation and electromyography (EMG) findings.
[Prevalence of immunologic markers (Anti-GAD and Anti-IA2) in first-degree relatives of patients with type I diabetes in the greater area of Sao Paulo].
Investigations were consistent with a cerebellar paraneoplastic disorder supported by a histologically proven diagnosis of SCLC, brain 18-FDG-PET findings, and positive anti-GAD antibodies [12, 13].
Anti-GAD antibodies were first described in type 1 diabetic Patients.
A month ago, a specialist did another anti-gad test and this time the reading was conclusive proof.
When known concentrations (0.5-12.5 RU/mL) of monoclonal anti-GAD antibodies were added to serum samples containing known concentrations of anti-TPO or anti-Tg autoantibodies, serum samples with anti-TPO autoantibodies showed little and samples with anti-Tg autoantibodies showed no cross-reactivity.
The double-blind, placebo-controlled crossover trial included 16 patients who had stiff-person syndrome and tested positive for antiglutamic acid decarboxylase (anti-GAD).
Blood glutamic acid decarboxylase antibody (anti-GAD) level was 2114 IU/mL (0-10) and the cerebrospinal fluid anti-GAD level was 4.07 nmol/L (<0.02).